NDC codes

466581 NDC codes with hospital pricing data in the network.

• NDC 5515016830 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (33 hospitals, 304–1,204 samples)
• NDC 5515025220 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (36 hospitals, 304–1,204 samples)
• NDC 5515025520 — LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION (57 hospitals, 304–1,204 samples)
• NDC 6332318505 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (41 hospitals, 304–1,204 samples)
• NDC 6332318507 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (50 hospitals, 304–1,204 samples)
• NDC 6332318508 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (45 hospitals, 304–1,204 samples)
• NDC 6332318509 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (43 hospitals, 304–1,204 samples)
• NDC 6332318510 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (68 hospitals, 304–1,204 samples)
• NDC 6332318520 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (68 hospitals, 304–1,204 samples)
• NDC 6332318550 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (66 hospitals, 304–1,204 samples)
• NDC 6332320102 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (47 hospitals, 304–1,204 samples)
• NDC 6332320103 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (26 hospitals, 304–1,204 samples)
• NDC 6332320202 — LIDOCAINE 20 MG/ML (2 %) INJECTION SOLUTION (PF OR NON-PF) (SO) (45 hospitals, 304–1,204 samples)
• NDC 6332346402 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (42 hospitals, 304–1,204 samples)
• NDC 6332346437 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (36 hospitals, 304–1,204 samples)
• NDC 6332348503 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (28 hospitals, 304–1,204 samples)
• NDC 6332348541 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (24 hospitals, 304–1,204 samples)
• NDC 6332348601 — LIDOCAINE 20 MG/ML (2 %) INJECTION SOLUTION (PF OR NON-PF) (SO) (27 hospitals, 304–1,204 samples)
• NDC 6332348602 — LIDOCAINE 20 MG/ML (2 %) INJECTION SOLUTION (PF OR NON-PF) (SO) (30 hospitals, 304–1,204 samples)
• NDC 6332349204 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (46 hospitals, 304–1,204 samples)
• NDC 6332349207 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (52 hospitals, 304–1,204 samples)
• NDC 6332349209 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (33 hospitals, 304–1,204 samples)
• NDC 6332349243 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (24 hospitals, 304–1,204 samples)
• NDC 6332349509 — LIDOCAINE (PF) 20 MG/ML (2 %) INJ SOLN (27 hospitals, 304–1,204 samples)
• NDC 6332349541 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (25 hospitals, 304–1,204 samples)
• NDC 6332373809 — FAMOTIDINE 10 MG/ML INTRAVENOUS SOLUTION (62 hospitals, 304–1,204 samples)
• NDC 6332373912 — FAMOTIDINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION (79 hospitals, 304–1,204 samples)
• NDC 6383376120 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (20 hospitals, 304–1,204 samples)
• NDC 6528216051 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (28 hospitals, 304–1,204 samples)
• NDC 6745744800 — FAMOTIDINE 10 MG/ML INTRAVENOUS SOLUTION (43 hospitals, 304–1,204 samples)
• NDC 6931590505 — LORAZEPAM 1 MG TABLET (44 hospitals, 304–1,204 samples)
• NDC 6937452005 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (21 hospitals, 304–1,204 samples)
• NDC 6937494905 — LIDOCAINE (PF) 100 MG/5 ML (2 %) INJECTION SYRINGE (46 hospitals, 304–1,204 samples)
• NDC 6937494935 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (21 hospitals, 304–1,204 samples)
• NDC 7128660061 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (20 hospitals, 304–1,204 samples)
• NDC 7257237001 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (24 hospitals, 304–1,204 samples)
• NDC 7257274701 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (20 hospitals, 304–1,204 samples)
• NDC 9999910133 — LIDOCAINE HCL 2 % MUCOSAL SOLUTION (20 hospitals, 304–1,204 samples)
• NDC 409909418 — Fentanyl Citrate Preservative Free (PF) Inj 250 MCG/5ML (65 hospitals, 601–1,204 samples)
• NDC 25021019282 — CIPROFLOXACIN 200 MG/100 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK (129 hospitals, 142–1,204 samples)
• NDC 39822050001 — HYDRALAZINE 20 MG/ML INJECTION SOLUTION (44 hospitals, 169–1,204 samples)
• NDC 00703003104 — methylPREDNISolone acetate 40 mg/mL suspension for injection (90 hospitals, 302–1,202 samples)
• NDC 00407294306 — GADOTERATE MEGLUMINE 2.5 MMOL/5 ML SOLUTION (31 hospitals, 581–1,202 samples)
• NDC 00407294370 — GADOTERATE MEGLUMINE 50 MMOL/100ML IV SOLN (14 hospitals, 581–1,202 samples)
• NDC 00407294317 — GADOTERATE MEGLUMINE 7.5 MMOL/15ML IV SOL PRESYRG (12 hospitals, 581–1,202 samples)
• NDC 63323-0360-01 — CALCIUM GLUCONATE 100 MG/ML (10%) IV SOLN (231 hospitals, 868–1,201 samples)
• NDC 67457-0220-05 — ISOSULFAN BLUE 1 % SC SOLN (260 hospitals, 472–1,201 samples)
• NDC 70594-0043-01 — VANCOMYCIN 1.5GM/300ML PREMIX (60 hospitals, 1,200 samples)
• NDC 0338170840 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (65 hospitals, 120–1,200 samples)
• NDC 0338171540 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (60 hospitals, 120–1,200 samples)